NO20060509L - Halvfaste systemer inneholdende azetidinderivater - Google Patents

Halvfaste systemer inneholdende azetidinderivater

Info

Publication number
NO20060509L
NO20060509L NO20060509A NO20060509A NO20060509L NO 20060509 L NO20060509 L NO 20060509L NO 20060509 A NO20060509 A NO 20060509A NO 20060509 A NO20060509 A NO 20060509A NO 20060509 L NO20060509 L NO 20060509L
Authority
NO
Norway
Prior art keywords
semi
systems containing
azetidine derivatives
solid systems
containing azetidine
Prior art date
Application number
NO20060509A
Other languages
English (en)
Norwegian (no)
Inventor
Maria-Teresa Peracchia
Sophie Cote
Valerie Bobineau
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20060509L publication Critical patent/NO20060509L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20060509A 2003-07-18 2006-01-31 Halvfaste systemer inneholdende azetidinderivater NO20060509L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03291796A EP1498122A1 (en) 2003-07-18 2003-07-18 Semi-solid systems containing azetidine derivatives
PCT/EP2004/008553 WO2005013973A1 (en) 2003-07-18 2004-07-08 Semi-solid systems containing azetidine derivatives

Publications (1)

Publication Number Publication Date
NO20060509L true NO20060509L (no) 2006-01-31

Family

ID=33462259

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060509A NO20060509L (no) 2003-07-18 2006-01-31 Halvfaste systemer inneholdende azetidinderivater

Country Status (30)

Country Link
US (2) US20050026898A1 (pt)
EP (2) EP1498122A1 (pt)
JP (1) JP2009513560A (pt)
KR (1) KR20060040691A (pt)
CN (1) CN1822831A (pt)
AR (1) AR045997A1 (pt)
AU (1) AU2004262498B2 (pt)
BR (1) BRPI0412737A (pt)
CA (1) CA2532669A1 (pt)
CR (1) CR8179A (pt)
EC (1) ECSP066292A (pt)
GT (1) GT200400135A (pt)
HR (1) HRP20060022A2 (pt)
IL (1) IL173111A0 (pt)
MA (1) MA27922A1 (pt)
MX (1) MXPA06000483A (pt)
MY (1) MY142077A (pt)
NO (1) NO20060509L (pt)
OA (1) OA13191A (pt)
PA (1) PA8606701A1 (pt)
PE (1) PE20050287A1 (pt)
RS (1) RS20060016A (pt)
RU (1) RU2343915C2 (pt)
SG (1) SG144141A1 (pt)
TN (1) TNSN06013A1 (pt)
TW (1) TW200522945A (pt)
UA (1) UA80633C2 (pt)
UY (1) UY28421A1 (pt)
WO (1) WO2005013973A1 (pt)
ZA (1) ZA200600490B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1817012A2 (en) * 2004-11-24 2007-08-15 Merck & Co., Inc. Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide
FR2923719B1 (fr) * 2007-11-15 2009-11-20 Sanofi Aventis Compositions pharmaceutiques a base de derives d'azetidine
CN101926757B (zh) 2010-09-01 2013-01-02 北京大学 一种难溶性药物的液体组合物及其制备方法
EP2637655B1 (en) * 2010-11-08 2019-01-09 Cadila Pharmaceuticals Ltd. Pharmaceutical composition of taxoids
CN105848643A (zh) * 2013-12-23 2016-08-10 强生消费者公司 消旋卡多曲组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996036316A1 (en) * 1995-05-19 1996-11-21 Abbott Laboratories Self-emulsifying formulations of lipophilic drugs
WO2000003753A2 (en) * 1998-07-14 2000-01-27 Em Industries, Inc. Microdisperse drug delivery systems
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6355631B1 (en) * 2000-03-03 2002-03-12 Aventis Pharma S.A. Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
FR2814678B1 (fr) * 2000-10-04 2002-12-20 Aventis Pharma Sa Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite
FR2829027A1 (fr) * 2001-08-29 2003-03-07 Aventis Pharma Sa Association avec un antagoniste du recepteur cb1, les compositions pharmaceutiques les contenant et leur utilisation pour le traitement de la maladie de parkinson
FR2833842B1 (fr) * 2001-12-21 2004-02-13 Aventis Pharma Sa Compositions pharmaceutiques a base de derives d'azetidine
EP1498123A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Emulsifying systems containing azetidine derivatives

Also Published As

Publication number Publication date
TNSN06013A1 (en) 2007-10-03
AR045997A1 (es) 2005-11-23
UA80633C2 (en) 2007-10-10
AU2004262498A1 (en) 2005-02-17
GT200400135A (es) 2005-08-25
SG144141A1 (en) 2008-07-29
IL173111A0 (en) 2006-06-11
ECSP066292A (es) 2006-10-25
CN1822831A (zh) 2006-08-23
UY28421A1 (es) 2005-02-28
RU2343915C2 (ru) 2009-01-20
RU2006105011A (ru) 2006-06-10
EP1648442A1 (en) 2006-04-26
BRPI0412737A (pt) 2006-09-26
HRP20060022A2 (en) 2006-02-28
AU2004262498A2 (en) 2005-02-17
RS20060016A (en) 2008-06-05
US20050026898A1 (en) 2005-02-03
JP2009513560A (ja) 2009-04-02
OA13191A (en) 2006-12-13
WO2005013973A1 (en) 2005-02-17
MA27922A1 (fr) 2006-06-01
CR8179A (es) 2006-09-22
AU2004262498B2 (en) 2009-01-22
US20080293686A1 (en) 2008-11-27
TW200522945A (en) 2005-07-16
MXPA06000483A (es) 2006-04-05
ZA200600490B (en) 2007-05-30
KR20060040691A (ko) 2006-05-10
CA2532669A1 (en) 2005-02-17
PE20050287A1 (es) 2005-06-13
MY142077A (en) 2010-08-30
EP1498122A1 (en) 2005-01-19
PA8606701A1 (es) 2005-02-04

Similar Documents

Publication Publication Date Title
NO20060510L (no) Emulgerende systemer inneholdende azetidinderivater
CY1116272T1 (el) Φαρμακευτικα σκευασματα που περιεχουν μεθυλναλτρεξονη
DE60305484D1 (de) Verbindungen und deren verwendung als 5-ht inhibitore
NO20052761L (no) Spirocykliske cykloheksanderivater.
NO20056130L (no) Nye substituerte 3-svovelindoler
CO5590918A2 (es) Formulaciones
DK1511489T3 (da) Nye farmaceutiske sammensætninger indeholdende flibanserin-polymorf A
SE0302573D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
DE602004031410D1 (de) Inden derivate als pharmazeutika
NO20060509L (no) Halvfaste systemer inneholdende azetidinderivater
SE0203303D0 (sv) Novel Compounds
SE0301699D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0300105D0 (sv) Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof
SE0302572D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
SE0300104D0 (sv) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
WO2004093796A3 (en) Lactam derivatives and methods of their use
SE0300103D0 (sv) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
CO5690574A2 (es) Nuevos compuestos derivados de indolina como inhibidores de la colesterol-actiltransferasa (acat) y uso medico del mismo
ATE394386T1 (de) 2-phenylpyran-4-on-derivate als selektive cox-2 inhibitoren
SE0300987D0 (sv) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
MXPA05012117A (es) Derivados de diarilmetiliden piperidina, preparaciones de los mismos y usos de los mismos.
SE0301441D0 (sv) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0301443D0 (sv) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application